Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder.
about
Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysisPharmacotherapy and psychotherapy for body dysmorphic disorderBody dysmorphic disorderCan understanding the neurobiology of body dysmorphic disorder (BDD) inform treatment?Body dysmorphic disorder and social phobia: cross-sectional and prospective data.Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness.Olanzapine augmentation of fluoxetine in body dysmorphic disorder.Recognizing and treating body dysmorphic disorder.Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity.Recognizing Body Dysmorphic Disorder (Dysmorphophobia).Delusional versus nondelusional body dysmorphic disorder: recommendations for DSM-5Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach.Symmetry Concerns as a Symptom of Body Dysmorphic DisorderBody dysmorphic disorder: treating an underrecognized disorder.Associations in the longitudinal course of body dysmorphic disorder with major depression, obsessive-compulsive disorder, and social phobia.Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?Body dysmorphic disorder: some key issues for DSM-V.Recent advances in understanding and managing body dysmorphic disorder.The problem of delusional ugliness: is it really body dysmorphic disorder?Pharmacotherapy for Body Dysmorphic Disorder.Obsessive-compulsive disorder after body dysmorphic disorder: a report of 2 cases (a man and his mother).Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder.Review of epidemiology, clinical presentation, diagnosis, and treatment of common primary psychiatric causes of cutaneous disease.Body dysmorphic disorder and olfactory reference disorder: proposals for ICD-11.Adjunctive antipsychotic in the treatment of body dysmorphic disorder - A retrospective naturalistic case note study.
P2860
Q21999508-E41926F3-B9F9-48AE-B684-85326FC070BCQ24241607-90E1246E-8376-4BB5-9185-7432E58566C3Q24635488-681897F7-70E1-4BAD-B82B-E35236A73431Q30977757-B99CCDE1-576F-4602-AB84-62D073CD835AQ31016727-2FA57DE5-6292-4682-836C-44C3D6B9016DQ33602052-B93E5FB9-D6E9-44B7-AA91-EAA5C24A0B6BQ35095144-EAA3819E-01E0-413E-A4ED-FD96AC975DD2Q35182122-A5BD20E7-EDCD-400C-8971-661343D6EB43Q35568961-5258D65E-47FA-4317-B379-CD94C9E75EECQ36280812-19DE80C7-3F08-4E07-8924-FFCB99741764Q37102253-725DB5A0-D233-4E95-9BC1-A25E4FADA8D0Q37104298-A17C6629-1396-4FB4-977B-2B9EDEB87652Q37177878-D1C9D07E-16DF-4F73-9502-6E50219D76D6Q37276266-C466419E-C626-4142-A76E-EB3D84044D87Q37450036-468DA96D-F64E-4E74-889A-6DE9496F8B78Q37700925-1B80F10A-C744-4458-96E8-F5BD52BD3077Q37700928-D517B433-CFDC-4E64-847A-FBE23CF99F40Q38654094-BF1CD599-9D87-403A-B17E-3757C7B59EFCQ40326827-9C99F6D7-A91C-4C5F-BF5A-B7B52B905E97Q41480222-CA67F3D0-4D98-4352-92DC-C5A96C6F54B6Q42161516-32390725-6B42-4DA5-849E-C481A70FC423Q46512031-A7ADE9EB-3281-4C28-A971-5FB472D7870AQ48156893-EE49244B-F28E-442C-8A74-49A0607E1E36Q50613495-C3FFA7BB-88DC-4294-AD45-009D3C838651Q50615494-E2558C0D-F4B0-4D4D-BCD7-114160FA9E67
P2860
Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Placebo-controlled study of pi ...... e in body dysmorphic disorder.
@ast
Placebo-controlled study of pi ...... e in body dysmorphic disorder.
@en
type
label
Placebo-controlled study of pi ...... e in body dysmorphic disorder.
@ast
Placebo-controlled study of pi ...... e in body dysmorphic disorder.
@en
prefLabel
Placebo-controlled study of pi ...... e in body dysmorphic disorder.
@ast
Placebo-controlled study of pi ...... e in body dysmorphic disorder.
@en
P2860
P1476
Placebo-controlled study of pi ...... e in body dysmorphic disorder.
@en
P2093
Katharine A Phillips
P2860
P304
P356
10.1176/APPI.AJP.162.2.377
P407
P577
2005-02-01T00:00:00Z